Guide for Authors
Guide for Authors
Performance Enhancement & Health is an international, peer-reviewed journal that critically explores the health implications of pharmacological, genetic, psychological and other technological enhancements of the human being. The journal is multi-disciplinary, examining the implications of performance enhancement on the human condition. Performance enhancement may be linked to productivity, identity, social capital or pleasure, while health is envisaged broadly as absence of disease, optimal functioning, and (personal or community) well-being. Performance Enhancement & Health welcomes papers, in English, on topics including, but not restricted to, the following:
• artistic expression
• body shape and image,
• cosmetic surgery,
• cyborgs and cyberhumans
• dietary practice and ergogenic aids
• injury prevention,
• quality of life,
• sex reassignment surgery
• sexual function
• sport and exercise,
• digitalisation and virtual reality
• workplace and school performance.
Submission of Manuscripts
Manuscripts are submitted online via http://ees.elsevier.com/peh
AudienceReview PolicyIn the first instance, an Editor-in-Chief or Associate Editor action-edits the paper within 2 weeks of submission to determine whether the paper should be sent for full review. Submissions accepted for full review are then subjected to a double-blind peer review process, with assessments finalised within 6 weeks of their acceptance for full review. It is the aim of the journal to respond to authors with feedback within 8 weeks from the original submission.
Physical (e.g. chemists, engineers, human factors, medical researchers, nutritionists, pharmacists, physicians, physicists, physiotherapists and sports and exercise scientists)
Social scientists (e.g. anthropologists, culture critics, demographers, economists, ethicists, geographers, historians, philosophers, policy analysts, political scientists, psychologists and sociologists)
Health, health care and allied health professionals and policy makers (e.g. epidemiologists, health educators, lawyers, managers, nurses, physiotherapists, public health practitioners, psychiatrists) interested in the contribution of performance technologies to human health.
Manuscript PresentationPlease read and follow the guidelines outlined below carefully:
The journal considers the following types of contribution:
1) Original quantitative, qualitative, critical, or mixed methodology research reports or analytical reviews in any area of theory, research, policy or practice relevant to performance enhancement and health. Submissions would typically be between 4000-7000 words, although longer articles may be considered with permission from an Editor-in-Chief or Associate Editor. These word lengths exclude Title page, Abstract, Acknowledgement, References section, Tables and Figure legends.
2) Short Reports. These are reports of research findings, commentaries on topical issues or correspondence, of less than 1500 words, including abstracts, tables and legends.
3) Editorials or Commentaries commissioned by the Editors.
4) Part or whole Special Issues bringing together collections of papers on a particular theme, and usually edited by a guest editor.
5) Letters in response to articles published in Performance Enhancement & Health, submitted electronically via the website. (300-word limit, and 3 references maximum)
• 12pt Times New Roman font
• 1.5x spacing
• 2.5cm or 1 inch margins (top, bottom, sides)
• Line numbers provided
• Page numbers in the bottom right-hand corner
• Track changes removed
Manuscript Structure (in order):2) Title Page:
1) Cover Letter:
• Authors must declare that manuscripts submitted to the Journal have not been published elsewhere or are not being considered for publication elsewhere and that the research reported will not be submitted for publication elsewhere until a final decision has been made as to its acceptability by the Journal.
• Conflict of Interest: when the proposed publication concerns any commercial product, either directly or indirectly, the author must include in the cover letter a statement (1) indicating that he or she has no financial or other interest in the product or distributor of the product or (2) explaining the nature of any relation between himself or herself and the manufacturer or distributor of the product. Other kinds of associations, such as consultancies, stock ownership, or other equity interests or patent-licensing arrangements, also must be disclosed. If, in the Editor's judgment, the information disclosed represents a potential conflict of interest, it may be made available to reviewers and may be published at the Editor's discretion; authors will be informed of the decision before publication. Note: if there are no Conflicts of Interest, simply state "The Author(s) have no conflicts of interest".
• concise and informative title, with no abbreviations.
• all authors listed by first name, all initials and family name
• Institution and affiliations - list the name and full address of all institutions where the study described was carried out. List departmental affiliations of each author affiliated with that institution after each institutional address. Connect authors to departments using alphabetical superscripts.
• Corresponding author - name and e-mail address only of the author to whom communications, proofs and requests for reprints should be sent.
3) Main manuscript must include:4) Tables and Figures - submitted separately from the main text manuscript.
• Abstract: a summary of the papers aim(s), method(s), results, conclusions and implications. 250 words or less.
• Key Words: 1 - 6 keywords that accurately reflect the theme, discipline(s), profession, method(s) of the work. Country specific research may wish to include the Country as one of the key words.
• Methods section with the following Regulatory Requirements:
• Research Protocol - Authors must state that the protocol has been approved by the appropriate Ethics Committee (state which)
• Human Investigation - The ethical guidelines that were followed by the investigators must be included in the Methods section of the manuscript. In Australia, all work should conform to the "Statement on Human Experimentation" by the National Health and Medical Research Council of Australia. State clearly that the subject gave informed consent. Anonymity should be preserved.
• Highlights: three to five dot (bulleted) points summarising the core results of the study - that can be understood by a lay audience. Avoid overly scientific terms and abbreviations. Dot points should not include recommendations for further research
• Acknowledgements: Grants, financial support, technical and other assistance such as equipement and drugs are acknowledged. If there was no financial assistance with the project, this must be clearly stated.
• Figure legends should be on a separate page, and numbered (Arabic) and in order of appearance. Identify (in alphabetic order) all abbreviations appearing in the illustrations at the end of each legend. Cite the source of previously published (print or electronic) material in the legend.
• Images or figures are submitted online as one or more separate files that may contain one or more images.
• Within each file, use the figure number (e.g., Figure 1A) as the image filename.
• The system accepts image files formatted in TIFF and EPS. PowerPoint (.ppt) files are also accepted, but you must use a separate PowerPoint image file for each PowerPoint figure.
• Symbols, letters, numbers and contrasting fills must be distinct, easily distinguished and clearly legible when the illustration is reduced in size.
• Black, white and widely crosshatched bars are preferable; do not use stippling, gray fill or thin lines.
• Written permission from unmasked patients appearing in photographs must be obtained by the authors and emailed to the editorial office once the manuscript is submitted online.
• Performance Enhancement & Health uses the APA referencing system. All publications cited in the text should be presented in a list of references following the text of the manuscript.
• In the text refer to the authors name (without initials) and year of publication e.g. "Since Peterson (1993) has shown that..." or "This is in agreement with results obtained later (Kramer, 1994)".
• For 2-6 authors, all authors are to be listed at first citation, with "&" separating the last two authors, for more than six authors, use the first six authors followed by "et al."
• In subsequent citations for three or more authors use "et al." in the text.
• The list of references should be arranged alphabetically by authors' names.
• The manuscript should be carefully checked to ensure that the spelling of authors' names and dates are exactly the same in the text as in the reference list.
• Responsibility for the accuracy of bibliographic citations lies entirely with the author(s).
• Citation of a reference as "in press" implies that the item has been accepted for publication.
• Authors are responsible for the accuracy of the content of the references.
This journal offers you the option of making your article freely available to all via the ScienceDirect platform. To prevent any conflict of interest, you can only make this choice after receiving notification that your article has been accepted for publication. The fee of USD 3,000 excludes taxes and other potential author fees such as color charges. In some cases, institutions and funding bodies have entered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements are available at http://www.elsevier.com/fundingbodies. Authors of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at http://www.elsevier.com/locate/openaccessform.pdf). Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article on your own website. More information can be found here: http://www.elsevier.com/authorsrights.